Loading clinical trials...
Loading clinical trials...
The main purpose of this study is to evaluate the efficacy and safety of retatrutide once weekly in participants with obesity and established cardiovascular disease (CVD). The study will last about 11...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Eli Lilly and Company
NCT06894498 · Obesity and Obesity-related Medical Conditions, Weight Loss
NCT07669168 · Health Services Accessibility, Rural Health, and more
NCT05124808 · Gestational Diabetes, Pregnancy, High Risk, and more
NCT06937086 · Ulcerative Colitis, Obesity or Overweight
NCT07256249 · Cardiovascular Diseases
Central Phoenix Medical Clinic
Phoenix, Arizona
Valley Clinical Trials, Inc.
Covina, California
Neuro-Pain Medical Center
Fresno, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions